外域
松弛素
化学
小分子
G蛋白偶联受体
受体
兴奋剂
细胞生物学
跨膜蛋白
跨膜结构域
蛋白质结构
生物物理学
生物化学
连接器
糖蛋白
血浆蛋白结合
糖基化
毛茛
生物
结合位点
HEK 293细胞
蛋白质-蛋白质相互作用
变构调节
蛋白质结构域
构象变化
肽序列
药物发现
作用机理
生物活性
逮捕
作者
James Osei‐Owusu,Tristan Girbau,Xunan Wang,Jeffrey S. Smith,Pengxiang Shen,Sarah C. Erlandson,Amanda K. Williamson,Xiaojing Cong,Mark W. Grinstaff,Daniel Kahne,Chérine Bechara,Andrew C. Kruse
出处
期刊:
[Cold Spring Harbor Laboratory]
日期:2026-06-11
被引量:1
标识
DOI:10.64898/2026.06.10.731386
摘要
RXFP1 is an unusual G protein-coupled receptor (GPCR) that mediates physiological adaptations to pregnancy and is a therapeutic target due to its benefits in treatment of fibrosis and heart failure. Protein and small-molecule agonists are currently in mid-stage clinical trials. Here, we present three cryo-electron microscopy structures of RXFP1: ligand-free, bound to the native agonist relaxin-2, and bound to the small-molecule drug candidate AZD5462. These structures show that relaxin-2 engages the receptor's ectodomain while AZD5462 binds within transmembrane domain. Together with hydrogen-deuterium exchange mass spectrometry, we show that relaxin-2 induces conformational reorganization of the linker domain into a helical secondary structure. In contrast, AZD5462 stabilizes a unique active conformation capable of inducing β-arrestin recruitment. Both mechanisms are distinctive from the "push-pull" mechanism of glycoprotein hormone receptors. Altogether, our findings define divergent activation mechanisms for protein and small-molecule agonists of RXFP1 and provide structural framework for next-generation drug discovery targeting relaxin receptors and their relatives.
科研通智能强力驱动
Strongly Powered by AbleSci AI